Was the HealthStream (HSTM) director’s share sale under a Rule 10b5-1 plan?

Yes. The filing states that the sales were effected pursuant to a Rule 10b5-1 sales plan adopted on November 21, 2025. Such plans allow insiders to pre-schedule trades, reducing the significance of trade timing as a signal of short-term expectations.

HealthStream director sells 6,000 shares at $29

HEALTHSTREAM INC director Linda Rebrovick reported an open-market sale of 6,000 shares of common stock on July 6, 2026 at a price of $29.00 per share.

Filing Impact

(Neutral)

Filing Sentiment

(Negative)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

HEALTHSTREAM INC director Linda Rebrovick reported an open-market sale of 6,000 shares of common stock on July 6, 2026 at a price of $29.00 per share. After this transaction, she directly holds 51,329 shares of HealthStream stock. The sale was carried out under a pre-arranged Rule 10b5-1 sales plan adopted on November 21, 2025, indicating the trade was scheduled in advance rather than timed discretionarily.

Insider Trade Summary 10b5-1

Net Seller: 6,000 shares

Net Sell 1 txn

Insider REBROVICK LINDA

Role Director

Sold 6,000 shs ($174K)

Type	Security	Shares	Price	Value
Sale	Common Stock Holding	6,000	$29.00	$174K

Holdings After Transaction: Common Stock Holding — 51,329 shares (Direct)

Footnotes (1)

F1. The sales reported in this Form 4 were affected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 21, 2025.

Key Figures

Shares sold: 6,000 shares Sale price: $29.00 per share Shares owned after sale: 51,329 shares +1 more

4 metrics

Shares sold 6,000 shares Open-market sale of common stock on July 6, 2026

Sale price $29.00 per share Price for 6,000 shares sold in open market

Shares owned after sale 51,329 shares Direct holdings following the reported transaction

Rule 10b5-1 plan adoption date November 21, 2025 Date director adopted pre-arranged sales plan

Key Terms

Rule 10b5-1 sales plan, open-market sale, Common Stock

3 terms

Rule 10b5-1 sales plan regulatory

"The sales reported in this Form 4 were affected pursuant to a Rule 10b5-1 sales plan adopted..."

open-market sale financial

"transaction_action: "open-market sale" for the 6,000-share disposition"

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Common Stock financial

"security_title: "Common Stock Holding" describing the shares involved"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did HealthStream (HSTM) director Linda Rebrovick report in this Form 4?

Director Linda Rebrovick reported selling 6,000 shares of HealthStream common stock. The shares were sold in an open-market transaction at $29.00 per share, and the transaction reflects a planned disposition under a previously adopted Rule 10b5-1 sales plan.

How many HealthStream (HSTM) shares did the director sell and at what price?

The director sold 6,000 shares of HealthStream common stock at $29.00 per share. This was an open-market sale, and the filing shows it was executed pursuant to a pre-arranged Rule 10b5-1 sales plan adopted in November 2025.

How many HealthStream (HSTM) shares does Linda Rebrovick hold after the sale?

After the transaction, Linda Rebrovick directly holds 51,329 shares of HealthStream common stock. This remaining position is disclosed in the Form 4 as the total shares beneficially owned following the reported open-market sale of 6,000 shares.

What type of transaction did the HealthStream (HSTM) Form 4 disclose?

The Form 4 discloses an open-market sale of common stock, coded as transaction type “S.” This indicates the director disposed of shares for cash in the market, rather than through option exercises, gifts, or tax-withholding related transactions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 07/07/2026 - 09:07 AM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

REBROVICK LINDA

(Last)

(First)

(Middle)

500 11TH AVENUE NORTH

SUITE 850

(Street)

NASHVILLE

TENNESSEE

37203

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
HEALTHSTREAM INC [ HSTM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/06/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock Holding	07/06/2026		S		6,000⁽¹⁾	D	$29	51,329	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. The sales reported in this Form 4 were affected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 21, 2025.

	/s/ Linda Rebrovick	07/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR